Decitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCT
Status:
Not yet recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
This randomized trial aimed at validating the efficacy and safety of low-dose decitabine,
together with umbilical cord blood in PGF post allo-HSCT patients.
Phase:
Phase 3
Details
Lead Sponsor:
The First Affiliated Hospital of Soochow University